Comorbidities in hereditary angioedema—A population‐based cohort study

BACKGROUND: In hereditary angioedema (HAE), low levels (type 1) or defect in function (type 2) of the serine‐protease inhibitor C1 Inhibitor protein results in activation of the classical pathway of the complement system as well as the contact system. Here, we investigated the risk of comorbidities...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundler Björkman, Linda, Persson, Barbro, Aronsson, David, Skattum, Lillemor, Nordenfelt, Patrik, Egesten, Arne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967273/
https://www.ncbi.nlm.nih.gov/pubmed/35344299
http://dx.doi.org/10.1002/clt2.12135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967273/
https://www.ncbi.nlm.nih.gov/pubmed/35344299
http://dx.doi.org/10.1002/clt2.12135

Ejemplares similares